STE NYSE Week ended 31 Jul 2026

Weekly Investor Report

STERIS plc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 228.4 USD
6.7% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 0.7% above the Trend Line and sits at 46.1% of its 52-week range. The latest completed week returned 6.7%, after a 4.7% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 49/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: earnings are due in 3d.

Setup score 48 out of 100
Latest Close 228.4 USD 31 Jul 2026
1W Return 6.7% latest completed week
4W Return 4.7% short-term follow-through
12W Return 10.4% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 6.7% Latest completed week; four-week move 4.7%. Indicator stack 32/91 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 49/100 conviction; expected move 6.7%. News sentiment 56/100 61 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 0.7% above the Trend Line and sits at 46.1% of its 52-week range. The latest completed week returned 6.7%, after a 4.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2612-week average 0.14

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.26Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 4.7% over four weeks, 10.4% over 12 weeks, and 1.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W6.7%
4W4.7%
12W10.4%
26W-12.5%
52W1.7%
Active trend streak0 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.50Latest activity-pressure read.
Pressure change399.5%Four-week change in activity pressure.
Leadership-11.31Latest relative-leadership reading.
RS change30.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength26/100Blend of value, momentum, and quality. Underlying universe rank 75; rank 1 is best.
Value21/100Relative valuation strength. Underlying universe rank 80; rank 1 is best.
Quality90/100Profitability and accounting quality. Underlying universe rank 11; rank 1 is best.
Momentum24/100Medium-term price momentum. Underlying universe rank 77; rank 1 is best.
Growth81/100Revenue and earnings growth. Underlying universe rank 20; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework47/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
26.7x
Price divided by trailing earnings.
Price / sales
3.5x
Market value relative to trailing revenue.
EV / EBITDA
12.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
7.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
44.2%
Gross profit retained from each unit of revenue.
Operating margin
18.6%
Operating profit retained from revenue.
Free-cash-flow margin
28.8%
Free cash flow generated from revenue.
Return on invested capital
9.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
8.7%
Latest one-year revenue growth.
EPS growth
27.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
12.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
9/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.9%
Cash dividends relative to market value.
Buyback yield
1.0%
Net share repurchases relative to market value.
Shareholder yield
1.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

STE shows bullish options pressure with a 49/100 conviction score, put-call volume ratio of 0.00, expected move of 6.7%, and Sharemaestro trend signal inactive.

Conviction49/100
Expected move6.7%
Put/call volume0.00
Pressure100
Speculation8
Volatility53
Trend agreement0
Open options detail
Insider activity1 / 19

1 acquisitions and 19 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 61 relevant articles.

21 positive · 34 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move6.7%Nearest-chain priced movement where available.
52-week drawdown-14.8%Distance below the 52-week high.
13-week volatility3.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+6.7%Week of 31 Jul.
Worst week-8.7%Week of 6 Mar.
Latest week+6.7%Week of 31 Jul.

Shape of recent returns

Strong gains2
Modest gains9
Flat weeks0
Modest losses13
Sharp losses2
Recent vol3.1%13-week weekly-return volatility.
Base vol3.4%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape45/100

Trend, activity pressure, participation, and risk combine to a 45/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.26; No reversal markers Factors40/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 31 SVQF47/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 532.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options46/100

STE shows bullish options pressure with a 49/100 conviction score, put-call volume ratio of 0.00, expected move of 6.7%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 6.7% Sentiment56/100

Weighted news tone is neutral across 61 relevant articles.

Does STERIS' (STE) 21-Year Dividend Streak Reveal Its True Capital Allocation Priorities? Insiders1 / 19

1 acquisitions and 19 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026228.4 USD6.7%226.7 USD224.7 USD0.50-11.314.2MOff
24 Jul 2026214.1 USD-1.7%227.4 USD224.6 USD0.33-16.243.0MOff
17 Jul 2026217.8 USD0.9%228.7 USD224.7 USD0.45-15.603.5MOff
10 Jul 2026216.0 USD-1.0%229.9 USD224.7 USD0.31-17.913.7MOff
3 Jul 2026218.2 USD1.2%231.0 USD224.8 USD0.10-16.313.3MOff
26 Jun 2026215.7 USD6.4%232.5 USD224.7 USD-0.14-15.894.7MOff
19 Jun 2026202.6 USD-2.4%234.1 USD224.7 USD-0.52-23.254.3MOff
12 Jun 2026207.6 USD-2.0%236.1 USD224.7 USD-0.66-21.183.6MOff
5 Jun 2026211.7 USD-0.2%237.7 USD224.7 USD-0.77-19.694.3MOff
29 May 2026212.1 USD-1.8%239.4 USD224.7 USD-0.97-22.063.2MOff
22 May 2026215.9 USD2.1%240.1 USD224.6 USD-1.07-20.074.0MOff
15 May 2026211.5 USD2.2%240.9 USD224.5 USD-1.20-21.576.2MOff
8 May 2026206.8 USD-3.2%241.8 USD224.4 USD-1.26-23.683.2MOff
1 May 2026213.8 USD-3.3%242.7 USD224.4 USD-1.24-19.783.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.